About: Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.18 (+4.50%)
ZURA NASDAQ Zura Bio Limited Class A Ordinary Shares
Zura Bio Limited Class A Ordinary Shares share price
ZURA price activity
Last Price
$4.180
Change (24hr)
0.18 USD (4.50%)
Volume
12.83M
Volume (4w avg)
-
Open
$3.95
Day Range
$3.95 - $4.18
Previous Close
$4.00
Last Trade
13 Oct, 3:52 pm GMT+0
Delayed
13 Oct, 3:52 pm GMT+0
ZURA price performance
Delayed
13 Oct, 3:52 pm GMT+0
ZURA Market Signals